Veloxis Pharmaceuticals at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Veloxis Pharmaceuticals brings 1 presentation to IDWeek 2026 in Washington, and exhibits at Booth 1713, 1715, BS 19, BS 20. Its program centres on herpes simplex virus infections that resist or fail to respond to treatment. It covers the burden of these infections and how to diagnose and manage them.

OrganizationIDWeek 2026 Attendance
veloxis.com
Large pharma
Specialty pharmaceutical company, part of Asahi Kasei, that develops and sells medicines for organ transplant recipients and related serious diseases.
Booth
Exhibiting at Booth 1713, 1715, BS 19, BS 20
Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm
Industry
Fri Oct 23
1:15pm–2:00pm
Rethinking Refractory and/or Resistant HSV Infections: Burden, Diagnosis and Management
Learning Lounge 2
with University of Miami
Antimicrobials, resistance and stewardship

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Veloxis Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction